K292-1519 Screening compound: 6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]hexanamide

K292-1519 Screening compound: 6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]hexanamide
K292-1519 Screening compound: 6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]hexanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K292-1519
6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]hexanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K292-1519

Molecular Formula

C31H32ClN3O4S3 (C31 H32 ClN3 O4 S3)

Compound Name

6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]hexanamide

IUPAC name

6-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]sulfanyl}-4-oxo-3H4H-thieno[32-d]pyrimidin-3-yl)-N-[2-(34-dimethoxyphenyl)ethyl]hexanamide

SMILES

COc(ccc(CCNC(CCCCCN(C1=O)C(SCc2csc(cc3)c2cc3Cl)=Nc2c1scc2)=O)c1)c1OC

InChI

InChI=1S/C31H32ClN3O4S3/c1-38-25-9-7-20(16-26(25)39-2)11-13-33-28(36)6-4-3-5-14-35-30(37)29-24(12-15-40-29)34-31(35)42-19-21-18-41-27-10-8-22(32)17-23(21)27/h7-10,12,15-18H,3-6,11,13-14,19H2,1-2H3,(H,33,36)

InChI Key

KZGATJQBPDOGIY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15091907

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

642.26

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.901

Distribution Coefficient, logD

5.901

Water Solubility, LogSw

-5.92

Polar Surface Area

67.088

Acid Dissociation Constant (pKa)

14.38

Base Dissociation Constant (pKb)

-0.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

K292-1519 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with K292-1519 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K292-1519?
Check Price and Availability of K292-1519, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K292-1519 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K292-1519
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K292-1519
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K292-1519 available by request